Announcements Trials
Browse Landscape

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 139Neoplasms 118Prostatic Neoplasms 64Lung Neoplasms 48Head and Neck Neoplasms 46Colorectal Neoplasms 38Ovarian Neoplasms 33Uterine Cervical Neoplasms 29Endometrial Neoplasms 23Motor Activity 22Neoplasm Metastasis 20Multiple Myeloma 20Pancreatic Neoplasms 19Brain Neoplasms 19Rectal Neoplasms 18Lymphoma 17Colonic Neoplasms 17Pain 16Gastrointestinal Neoplasms 16Fatigue 16Carcinoma, Non-Small-Cell Lung 16Leukemia 15Depression 15Oropharyngeal Neoplasms 13Melanoma 13Anxiety Disorders 13Urinary Bladder Neoplasms 12Hematologic Neoplasms 12Esophageal Neoplasms 12Stomach Neoplasms 11

Interventions

testosterone undecanoate 4Testosterone 3Alendronate 2testosterone 17 beta-cypionate 1Triptorelin Pamoate 1Testosterone Propionate 1Tamoxifen 1Surveys and Questionnaires 1Standard of Care 1Specimen Handling 1Practice Guidelines as Topic 1Pioglitazone 1Orchiectomy 1Observation 1Methyltestosterone 1Mental Status and Dementia Tests 1Gonadotropin-Releasing Hormone 1Gels 1Drug Evaluation 1Clomiphene 1Castor Oil 1Blood Specimen Collection 1Anastrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hypogonadism × Surveys and Questionnaires × Clear all
NCT00529230 2018-10-25

Prevalence of Secondary Hypogonadism in Male Patients on Chronic Opioid Therapy for Cancer-Related Pain Syndromes

M.D. Anderson Cancer Center

Terminated
46 enrolled

Hypogonadism, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡